Sepsis: all 1,946 studies

Page 17 of 20. Open to participants first (471), then studies with results posted, then the rest; newest registration first within each.

• Identification Sepsis Related Single Nucleotide Polymorphism (SNP) by Whole Exome SequencingStatus unknownNCT01920217
• Outcomes of Severe Sepsis Patients in Surgical Intensive Care UnitsCompletedNCT01919138
• Observational, Prospective Clinical Study to Evaluate Biomarkers as Indicators of Acute Bacterial or Viral InfectionsCompletedNCT01917461
• Molecular Diagnosis and Risk Stratification of SepsisStatus unknownNCT01905033
• Epidemiology of Septic Shock in Medical or Polyvalent ICU in the North-East Region of FranceTerminatedNCT01903746
• Determination of the Nature of the Endogenous Ligand of TREM-1 and Its Use as a New Diagnostic Biomarker in SepsisWithdrawnNCT01903668
• Umbilical Cord Care for the Prevention of ColonizationStatus unknownNCT01893060Not applicable
• Methionine Metabolism in Parenterally Fed Pediatric SepsisCompletedNCT01891682
• Gluconeogenesis Rates and Its Precursors in Pediatric SepsisCompletedNCT01890928
• Methionine Metabolism in Enterally Fed Pediatric SepsisCompletedNCT01889264
• Immune Resolution After Staphylococcus Aureus BacteremiaActive, not recruitingNCT01879761
• Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic ShockCompletedNCT01867905
• The Impact of IVIG Treatment on Critical Illness Polyneuropathy and/or Myopathy in Patients With MOF and SIRS/SepsisTerminatedNCT01867645Phase 1
• Neonatal Suspected Sepsis Treated With Cefazolin or VancomycinCompletedNCT01867138Phase 3
• The Effect of Semi-quantitative Procalcitonin Assay to The Adequacy of Empirical Antibiotics and Mortality in Septic PatientsCompletedNCT01862185Phase 3
• Efficacy of Melatonin in Patients With Severe Sepsis or Septic ShockStatus unknownNCT01858909Phase 3
• HSPA12B as a Potential Biomarker for Sepsis and Severe SepsisCompletedNCT01847248
• Effects of Early Exercise Rehabilitation on Long-term Functional Recovery in Patients With Severe SepsisCompletedNCT01845766Not applicable
• Prognostic Evaluation Of Severe Sepsis And Septic Shock. Procalcitonin Versus Delta SofaStatus unknownNCT01841190
• Alpha-1-acid Glycoprotein as a Biomarker of Developmental Diagnosing and Monitoring Effectiveness in SepsisStatus unknownNCT01838525
• Clinical Trial With Catheter Locking TauroSept® (Taurolidine 2%) or Saline Solution 0,9%CompletedNCT01826526Not applicable
• Oral Lactoferrin Supplementation for Prevention of Sepsis in Preterm NeonateStatus unknownNCT01821989Early Phase 1
• Amino Acids Expression Profiling of Patients With SepsisStatus unknownNCT01818830
• Activated Protein C and MicrocirculationCompletedNCT01806428
• Lotta Alla Sepsi Ospedaliera - Fighting Hospital SepsisCompletedNCT01804764
• Methylene Blue in Severe Sepsis and Septic ShockStatus unknownNCT01797978Phase 3
• Efficacy of Online Hemodiafiltrationlysis in Cytokine RemovalCompletedNCT01791712Not applicable
• Impact of CVVHD With Adsorption Capacity Membranes in Septic Acute Kidney InjuryCompletedNCT01790620Not applicable
• Early Physical Therapy in Patients With SepsisTerminatedNCT01787045Not applicable
• Clinical Significance of Intra-abdominal Hypertension in Surgical Patients With Severe SepsisCompletedNCT01784458
• ASpirin for Patients With SEPsis and SeptIc ShockTerminatedNCT01784159Phase 2
• Dose-response Study of Arginine Supplementation in Severe SepsisCompletedNCT01775020Early Phase 1
• Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to Extended-spectrum Beta-lactamase (ESBL) or Carbapenemase-producing Enterobacteriaceae: an Observational Multinational StudyCompletedNCT01764490
• Dexmedetomidine for Sepsis in ICU Randomized Evaluation TrialCompletedNCT01760967Phase 4
• Endotoxin Adsorber Hemoperfusion and MicrocirculationCompletedNCT01756755Not applicable
• Improved Accessibility of EmONC Services for Maternal and Newborn Health: a Community Based ProjectCompletedNCT01751945Not applicable
• Monitoring Resuscitation in Severe Sepsis and Septic ShockStatus unknownNCT01747057Not applicable
• Procurement of Human Specimens for the Evaluation of Early Markers of SepsisCompletedNCT01746407
• Pharmacokinetics (PK) of Antistaphylococcal Antibiotics in Infants (NICHD-2012-02-Staph Trio)CompletedNCT01728363Phase 1
• Ultrasound Measurement of Reactive Hyperemia in Critical CareCompletedNCT01726595
• Study of the Function of Cells Involved in Inflammation in the Lungs of Those With Acute Lung Injury and SepsisCompletedNCT01725061
• Electronic Application of a Severe Sepsis Screening Tool and Management BundleStatus unknownNCT01724463
• Melatonin in Healthy VolunteersCompletedNCT01724424Phase 1
• Chlorhexidine Skin Application for Prevention of Infection in Infants Weighing <1500 g at BirthWithdrawnNCT01723501Phase 2/3
• Muscle Atrophy in Patients With Severe SepsisTerminatedNCT01717651
• Lactate Clearance According to the Presence of Hepatic DysfunctionStatus unknownNCT01709565
• EVLWI Exhibits Pulmonary and Systemic Permeability in Sepsis Related ALI/ARDSStatus unknownNCT01694147
• Sepsis in Neutropenic Patients: Autologous Stem Cell Transplantation as Model: a Transcriptomic ApproachStatus unknownNCT01693952Not applicable
• Examination of the Impact of Better Surveillance and Communication of Patient Deterioration on Patient Related OutcomesCompletedNCT01692847
• Simplified Severe Sepsis Protocol-2 (SSSP-2) in ZambiaCompletedNCT01663701Not applicable
• Impact of Early Goal-directed Fluid Therapy in Septic Patients Undergoing Emergency SurgeryTerminatedNCT01654003Not applicable
• PROcalcitonin to SHORTen Antibiotics Duration in PEDiatricICU Patients (ProShort-Ped) TrialStatus unknownNCT01652404Phase 3
• The Effects of Interferon-gamma on Sepsis-induced ImmunoparalysisCompletedNCT01649921Phase 3
• Sepsis MetabolomicsCompletedNCT01649440
• Impact of Catheter Design on Catheter Survival in Chronic Hemodialysis PatientsCompletedNCT01649102Phase 4
• Examination of ADMA Serum Level and DDAH IICompletedNCT01632059
• De-escalation of Empirical Antimicrobial Therapy Study in Severe SepsisCompletedNCT01626612Phase 3
• Central Venous Catheter Replacement Strategies in Adult Patients With Major Burn InjuryStatus unknownNCT01603914Not applicable
• Selenium Replacement and Serum Selenium Level in Severe Sepsis and Septic Shock PatientsWithdrawnNCT01601938Phase 2
• Outcome Following Vitamin C Administration in SepsisStatus unknownNCT01590303Phase 2
• Procalcitonin in Cirrhotic Patients at High Risk for SepsisCompletedNCT01578226
• Pharmacology of Exenatide in Pediatric SepsisWithdrawnNCT01573806Phase 1/2
• A Prospective Study of The Complement Depletion in Patients With Severe Abdominal SepsisCompletedNCT01568853Not applicable
• AgION Catheter for Preventing Catheter-Related Bloodstream InfectionsCompletedNCT01564615Not applicable
• Effects of Acute Systemic Inflammation on Arterial Stiffness and Microcirculation.CompletedNCT01556373
• Efficacy, Pharmacokinetics and Safety of Meropenem in Infants Below 90 Days With Clinical or Confirmed Late-onset SepsisCompletedNCT01551394Phase 3
• Antimicrobial Catheter Securement Dressings for the Prevention of Cvc-related Bloodstream Infections in Cancer PatientsCompletedNCT01544686Not applicable
• Investigation of the Role of Brain Natriuretic Peptide and Lactate in Early Goal-directed Therapy for Patients With Severe Sepsis and Septic ShockStatus unknownNCT01539551
• Hepcidin Levels in Preterm InfantsCompletedNCT01539356
• Antimicrobial Catheter Lock Solution for the Treatment of Central Line Associated Bloodstream Infection (CLABSI)CompletedNCT01539343Phase 2
• Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With SepsisStatus unknownNCT01535534
• Integrilin and Ilomedin in Combination in Comparison to Standard Treatment in Severe Pneumonia Patients With Severe SepsisTerminatedNCT01532544Phase 2
• Immune Activation, Hypoxia and Vasoreaction in Sepsis of Pulmonary Versus Abdominal OriginCompletedNCT01530932
• Plasma Free Fatty Acids in Risk Assessment of Sepsis in the Emergency Department: A Prospective Pilot StudyCompletedNCT01530854
• Lactoferrin for Prevention of Sepsis in InfantsCompletedNCT01525316Phase 3
• Procalcitonin Monitoring Sepsis StudyCompletedNCT01523717
• National Study on Listeriosis and ListeriaCompletedNCT01520597
• Comparing an Automated to a Conventional Sepsis Clinical Prediction RuleWithdrawnNCT01505478
• Association Between cd163 Gene Polymorphisms and Sepsis Among Chinese Han PopulationStatus unknownNCT01504243
• Biomarkers in Exhaled Breath Condensates of Septic Patients to Predict Development of Multi-organ Dysfunction SyndromeStatus unknownNCT01503684
• The Impact of Continuous Renal Replacement Therapy on the Outcomes of Burn Patients With Early Phase of SepsisStatus unknownNCT01501097Not applicable
• Procalcitonin as a Tool to Shorten Antibiotic Therapy in the ICUCompletedNCT01494675Not applicable
• The Changes of CD4+T Lymphocyte Subsets in Septic PatientsStatus unknownNCT01494389
• Urinary Proteomics Analysis for Sepsis and PrognosisStatus unknownNCT01493492
• Serum Proteomics Analysis for SepsisStatus unknownNCT01493466
• TREM-1 Gene PolymorphismsCompletedNCT01490424
• Pharmacogenomic Biomarker Study for Recombinant Human Activated Protein C Treatment in Severe SepsisStatus unknownNCT01486524
• Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe SepsisCompletedNCT01484106Not applicable
• Anticipative Diagnosis of Central Venous Catheter Related Bloodstream InfectionsCompletedNCT01481038
• Personalized Mean Arterial Pressure Management on Renal Function During Septic ShockTerminatedNCT01473498Not applicable
• System-level Monitoring of Immune Activation Concerning Susceptibility to Sepsis in Trauma PatientsWithdrawnNCT01472952
• MiRNAs Evaluate the Prognosis of Sepsis by Dynamic StudyStatus unknownNCT01459822
• Emergency Department Management of Sepsis Patients: A Goal-Oriented Non-Invasive Sepsis TrialCompletedNCT01453270Not applicable
• Evaluation in the Treatment of Nosocomial Sepsis Comparing Polymerase Chain Reaction With Conventional Blood Culture.CompletedNCT01450358Phase 4
• Simplified Severe Sepsis Protocol in ZambiaTerminatedNCT01449916Not applicable
• Indocyanine Clearance Rate and Septic Liver InjuryStatus unknownNCT01447836
• Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of CareCompletedNCT01431326
• Critical Care Excellence in Sepsis and TraumaCompletedNCT01426711
• Effect of Lipopolysaccharide on Skeletal Muscle FunctionsCompletedNCT01423968Not applicable
• Life After Pediatric Sepsis EvaluationCompletedNCT01415180

← Sepsis overview